| |
Research and Development
 |
For many years Probiotics International has been involved in research and development into Probiotic formulations for all animals including companion animals, equine and humans. The focus of the R&D changes as the company diversifies into more specialist formulations and as new advances in research work can be carried out.
Over the past year Probiotics International has been working closely with the Veterinary Laboratories Agency, Weybridge, UK on a number of key projects to:
- Ensure the safety and quality control of Protexin probiotic formulations
- Demonstrate (and where possible visualise) the key mechanisms of action by which Protexin probiotic microorganisms actually work including
- adhesion in gut line cell culture
- competitive exclusion in cell culture and in vivo in poultry
- production of cytokines (communicating chemicals between probiotic microorganisms and the body's own immune cells)
- production of natural bacteriocins
The Probiotic concept is still the principal element to all R&D but many formulations now contain other important active ingredients such as the Prebiotic Preplex.
The challenges for good gut health remain as the demands change.
We are constantly refining products to take on the challenges as replacements for AGP's following the EU ban on January 1st 2006 or to offer patients a way of maintaining and re-establishing their gut microflora during and after antibiotic therapy. In companion animals we offer products that act to aid normalisation of gut peristalsis.
Research work combined with new product development into complete ranges of formulations for all animals and manufacturing accreditations including ISO9001:2000, FEMAS, GMP Pharmaceutical and RPSGB/VMD ensures that Probiotics International Ltd can offer unique and high quality products in all sectors to the domestic, European and International market.
Probiotics International Ltd continue to develop unique combinations of synergistic ingredients and formulations that work well in all animals and humans.
|
|
|
|
